Table of Contents
ISRN Pediatrics
Volume 2014 (2014), Article ID 758343, 6 pages
http://dx.doi.org/10.1155/2014/758343
Clinical Study

Influence of the Type of Basal Insulin and Other Variables on Clinical Outcomes in Children with Newly Diagnosed Type 1 Diabetes

1Ambulatory Care, Veterans Affairs Medical Center, 921 NE 13th Street, Oklahoma City, OK 73104, USA
2Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, 4502 East 41st Street, Suite 1H05, Tulsa, OK 74135, USA
3Department of Pediatrics, University of Oklahoma School of Community Medicine, 4502 East 41st Street, Tulsa, OK 74135, USA
4Department of Pharmacy, Clinical and Administrative Sciences-Tulsa, University of Oklahoma College of Pharmacy, P.O. Box 26901, Oklahoma City, OK 73126, USA
5Harold Hamm Oklahoma Diabetes Center, Tulsa Program, University of Oklahoma School of Community Medicine, 4502 East 41st Street, Tulsa, OK 74135, USA

Received 20 October 2013; Accepted 26 December 2013; Published 6 February 2014

Academic Editors: D. V. Milford, O. Mishra, H. Neville, S. A. Sarker, and B. Vasarhelyi

Copyright © 2014 Ruth M. Garrison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Basal insulin detemir and glargine each have characteristics that may make them a superior choice in children and adolescents with type 1 diabetes, but there is a paucity of data on glycemic results in this population. Objective. Examination of variables associated with achievement of HbA1c goal in children and adolescents with newly diagnosed type 1 diabetes. Methods. The primary outcome, factors associated with achievement of HbA1c goal, was examined in a retrospective chart review. Variables, including type of basal insulin, were collected during the first year of diagnosis of patients in a pediatric diabetes clinic. Secondary outcomes included change in HbA1c, severe hypoglycemic events, and episodes of DKA. Results. 94 patients were included in the study. HbA1c at diagnosis was found to be a significant predictor of achievement of goal at 3 months ( ) and of change in HbA1c at 3 and 12 months ( for each). Severe hypoglycemia and episodes of DKA were uncommon. Conclusions. Choice of basal insulin was not found to be a predictor of achieving HbA1c goal or of change in HbA1c over the course of the first year of diagnosis with type 1 diabetes.